Company Strategy

The KineMed business strategy is to increase  R&D productivity and the rate of value creation in pharmaceutical drug development. We believe the key to accomplishing these goals is provide cost effective decision-relevant clinical data on drug activity and patient stratification earlier in the drug development process. KineMed is actively working with multiple pharmaceutical partners and on its own product pipeline, applying its technology to enable this type of evidence-based drug development, thus adding value at each step of the development process.